LON:AZN - AstraZeneca Stock Price, News, & Analysis

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca declared a dividend on Thursday, February 14th. Shareholders of record on Thursday, February 28th will be given a dividend of GBX 146.80 per share on Wednesday, March 27th. This represents a yield of 2.57%. The ex-dividend date is Thursday, February 28th. This is an increase from AstraZeneca's previous dividend of $68.40. The official announcement can be accessed at this link. View AstraZeneca's Dividend History.

AstraZeneca is scheduled to release their next quarterly earnings announcement on Thursday, July 25th 2019. View Earnings Estimates for AstraZeneca.

19 Wall Street analysts have issued 12-month price targets for AstraZeneca's stock. Their forecasts range from GBX 5,000 to GBX 8,500. On average, they expect AstraZeneca's stock price to reach GBX 6,497.06 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View Analyst Price Targets for AstraZeneca.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 sell ratings, 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AstraZeneca.

Headlines about AZN stock have trended somewhat positive on Monday, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca earned a news sentiment score of 1.4 on InfoTrie's scale. They also assigned news stories about the biopharmaceutical company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for AstraZeneca.

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Pharmaxis (PXS), Allergy Therapeutics (AGY), Futura Medical (FUM) and Vita Life Sciences (VLS).

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Hain Celestial Group (HAIN), Vodafone Group (VOD), National Retail Properties (NNN), BP (BP), NVIDIA (NVDA), Philip Morris International (PM), Marks and Spencer Group (MKS), British American Tobacco Plc Ads (BATS) and Ford Motor (F).

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 6,250.

AstraZeneca has a market capitalization of £81.99 billion and generates £22.40 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.View Additional Information About AstraZeneca.

The official website for AstraZeneca is http://www.astrazeneca.com/.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.